EVO Visian ICL

Once the implantable collamer artificial lens implantation is complete, the EVO Visian ICL lens does not move, and you should not be able to feel or see it.

The EVO ICL is designed to not interfere with any of the eye’s structures and maintain its place on its own. It is implanted between the patient’s natural crystalline lens and the iris (colored part of the eye). The EVO is biocompatible and once it is in place it does not move.

You should inquire about the EVO Visian ICL even if your eye doctor has advised against LASIK or PRK since it is effective for individuals with a variety of lifestyles and vision goals. EVO Visian ICL has been designed to treat moderate myopia (nearsightedness) and even high myopia and is also an option if you have thin corneas. It can also treat myopic astigmatism and moderate myopic astigmatism.

The EVO ICL (implantable collamer lens) is an additive technology that corrects eyesight without removing any corneal tissue, in contrast to several other vision correction solutions. Unlike other permanent types of vision correction surgery, the EVO lenses are removable and designed to lessen or eliminate the need for glasses or contact lenses.

With and without astigmatism, the FDA has approved EVO ICL for a variety of myopic (nearsightedness) correction needs. Even though EVO ICL is less advertised than LASIK or other treatments, it has long been shown to be secure, safe, reliable, and no adverse effects. At your evaluation appointment, your ClearSight eye surgeon will go through and discuss any potential risks related to EVO ICL and make sure you feel confident about your decision to have vision correction surgery.

Before approving the EVO Visian ICL, the FDA (Food and Drug Administration) investigated it for many years in the clinical trials. Prior to FDA approval in the United States, EVO ICLs had also been used for over ten years in Europe and Asia, where a lengthy 10-year study had shown their stability and safety. In this research, there were no long-term problems and no incidence of infection or cataract development throughout the 10-year follow-up period. Worldwide, more than a million EVO operations have been performed. The Visian ICL, EVO’s predecessor, has been in use in the US since 2005 and has almost the same safety record.

The lens’ full detachability is one of EVO ICL’s many advantages. ICL lenses are worn permanently by the vast majority of patients. However, you can be reassured to know that you have the choice to remove them if your prescription (refraction) changes or if any other health issues arise. Despite the low likelihood of needing them removed, it is reassuring to have the option.

Myopia and high myopia (seeing things in a distance is difficult) are both corrected with EVO ICL procedures. Hyperopia (farsightedness, meaning reading and viewing close objects is challenging) is not corrected with EVO ICL. Presbyopia, a loss of reading vision that is a normal part of aging, is another condition that EVO Visian ICLs can not address.

The majority of patients feel little to no pain during or after surgery. Some patients report feeling pressure on their eyes, although they do not state that it is painful. Because the EVO ICL technique only requires a small, self-healing incision, it often causes less discomfort and requires less time to recuperate than some other vision correction procedures.

The majority of Implantable Collamer Lens procedures are finished in about 15 minutes. Almost immediately, patients notice a remarkable improvement in their vision. You will be amazed at how clear and improved your vision is right after surgery. The next day, you will likely be able to go back to their jobs or regular activities with your visual acuity approving each day.

In order to correct myopia and myopic astigmatism, the EVO ICL, sometimes called implantable contact lens, is implanted in a patient’s eye. Up to 20D of myopia and up to 4D of astigmatism may be treated with the EVO ICL medical procedure. The best approach to determine whether EVO ICL is appropriate for you is to arrange a consultation during which you may discuss your vision correction options with the ClearSight team.

If any of the following apply, EVO ICL may be right for you:

• You’re searching for a vision correction treatment for moderate to severe nearsightedness (with or without astigmatism)
• Your prescription has not changed considerably in the last 12 months.
• Your eyes are in good health besides being nearsighted or astigmatic